NCT06441864 Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder
| NCT ID | NCT06441864 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Nightmare |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-07-15 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member residing in the same home). All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their family members will attend 2 of those sessions with them.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease * Age 18 or older * Speak, read, and write English * Live in the United States * Nightmare frequency ≥3 times per week * Disturbing Dream and Nightmare Severity Index score indicative of nightmare disorder * Sleep, neurological, and psychiatric medications stable for at least 1 month and willing to keep medications stable through the course of the study * Live with a family member who is willing to participate in the study Exclusion Criteria: * Possible dementia * Narcolepsy * Posttraumatic stress disorder * Previous behavioral treatment for nightmares * Currently engaged in sleep- or trauma-focused psychotherapy * Taking a medication that could cause RBD, if the medication was started prior to onset of RBD symptoms Inclusion Criteria (Family Members): * Live with a family member who meets all of the above criteria * Age 18 or older * Speak, read, and write English * Live in the United States
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06441864 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nightmare. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06441864 currently recruiting?
Yes, NCT06441864 is actively recruiting participants. Contact the research team at RBDstudy@utah.edu for enrollment information.
Where is the NCT06441864 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT06441864 clinical trial?
NCT06441864 is sponsored by University of Utah. The trial plans to enroll 20 participants.